Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy

• Status: Completed
• Trial end date: 2006-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Validation of qolie-10, an epilepsy specific quality of life questionnaire in patients treated with lamotrigine or valproic acid. Comparison of quality of life of epileptic patients treated with lamotrigine or valproic acid. Determination and assessment of the comparative safety of lamotrigine or valproic acid. Assessment and comparison of body image perception in women treated with lamotrigine or valproic acid.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Anticonvulsants; Lamotrigine; Valproic Acid

Criteria

Inclusion criteria:

• Diagnosis of epilepsy and normal neurological examination.

• Patients receiving lamotrigine or valproic acid at stable doses in monotherapy initiated 2 -4 months before.

Exclusion criteria:

• Pregnant or lactating women.

• Previous treatment with lamotrigine or valproic acid.

• Secondary epilepsy.